The inspection was conducted by ANVISA from 7 June 2026 to 11 June 2026 at the company's Unit II situated at Chincholi, Solapur, Maharashtra.
According to the inspection report, the establishment has been classified as "Complies with Good Manufacturing Practices with Corrective Action." The report further indicates that the establishment has conditions for certification in respect of the inspected active pharmaceutical ingredient (API).
The company clarifies that while this inspection report represents an important development in the process, the final GMP certificate has not yet been received as of the date of this intimation (21 October 2026).
Smruthi Organics has committed to making further disclosures, as applicable, upon receipt of the final GMP certificate.
The disclosure was submitted to both BSE Limited and Metropolitan Stock Exchange of India Ltd for information and records.